Roundtable on Advances in Cell & Immunotherapies in Treating Cancer

GenomeWeb convened a panel of cancer immunology experts to discuss the latest advances in the field and obstacles to its progress, and strategies that combine multiple therapeutic modalities in the development of effective and safe therapies.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Recent advances and current strategies in developing vaccines and immunotherapies against cancer
Specific assays that identify different populations of immune cells, their functional status, and interaction in response to cancer
The systemic response of local stereotactic body radiation therapy or SBRT with checkpoint inhibitor immunotherapy in cancer patients
How single cell-based technology can be useful in characterizing the tumor microenvironment in adoptive immunotherapy such as CAR-T cells
A Deeper Look

More about this

Advances in Treating Cancer

Cellular and immune therapies in cancer treatment have come a long way in the few decades since the first cDNA
piece of the human T-cell receptor gene was cloned in 1984.

We now have the tools to transform cold tumors, adept at
evading the immune system, into hot tumors that stand a better chance at being seen by the immune system and
therapeutically targeted. 

Yet, we have much to learn.

Download this eBook to hear four experts share their thoughts and discuss the progress in their respective fields.

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Get the